These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35832423)

  • 1. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
    Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
    Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific association of serum dehydroepiandrosterone and its sulfate levels with osteoporosis in type 2 diabetes.
    Li S; Li W; Chang L; Wan J; Chen S; Zhang X; He Q; Liu M
    J Bone Miner Metab; 2024 May; 42(3):361-371. PubMed ID: 38769209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study.
    Brahimaj A; Muka T; Kavousi M; Laven JS; Dehghan A; Franco OH
    Diabetologia; 2017 Jan; 60(1):98-106. PubMed ID: 27771738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.
    Tivesten Å; Vandenput L; Carlzon D; Nilsson M; Karlsson MK; Ljunggren Ö; Barrett-Connor E; Mellström D; Ohlsson C
    J Am Coll Cardiol; 2014 Oct; 64(17):1801-10. PubMed ID: 25443702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum DHEA and Its Sulfate Are Associated With Incident Fall Risk in Older Men: The MrOS Sweden Study.
    Ohlsson C; Nethander M; Karlsson MK; Rosengren BE; Ribom E; Mellström D; Vandenput L
    J Bone Miner Res; 2018 Jul; 33(7):1227-1232. PubMed ID: 29528519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of endogenous DHEA/DHEAS with coronary heart disease: A systematic review and meta-analysis.
    Wu TT; Gao Y; Zheng YY; Ma YT; Xie X
    Clin Exp Pharmacol Physiol; 2019 Nov; 46(11):984-994. PubMed ID: 31347187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study.
    Johannes CB; Stellato RK; Feldman HA; Longcope C; McKinlay JB
    J Clin Epidemiol; 1999 Feb; 52(2):95-103. PubMed ID: 10201649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women.
    Jia X; Sun C; Tang O; Gorlov I; Nambi V; Virani SS; Villareal DT; Taffet GE; Yu B; Bressler J; Boerwinkle E; Windham BG; de Lemos JA; Matsushita K; Selvin E; Michos ED; Hoogeveen RC; Ballantyne CM
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4304-27. PubMed ID: 32785663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do DHEA/DHEAS play a protective role in coronary heart disease?
    Porsová-Dutoit I; Sulcová J; Stárka L
    Physiol Res; 2000; 49 Suppl 1():S43-56. PubMed ID: 10984071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study.
    Feldman HA; Johannes CB; McKinlay JB; Longcope C
    Ann Epidemiol; 1998 May; 8(4):217-28. PubMed ID: 9590600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum dehydroepiandrosterone is associated with diabetic dyslipidemia risk in males with type 2 diabetes.
    Chen S; Li S; Zhang X; Fan Y; Liu M
    Front Endocrinol (Lausanne); 2023; 14():1272797. PubMed ID: 38075062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum albumin, aspartate aminotransferase, and body mass are risk factors for frailty in elderly people with diabetes-a cross-sectional study.
    Yanagita I; Fujihara Y; Iwaya C; Kitajima Y; Tajima M; Honda M; Teruya Y; Asakawa H; Ito T; Eda T; Yamaguchi N; Kayashima Y; Yoshimoto M; Harada M; Yoshimoto S; Aida E; Yanase T; Nawata H; Muta K
    BMC Geriatr; 2020 Jun; 20(1):200. PubMed ID: 32517659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.
    Ohlsson C; Labrie F; Barrett-Connor E; Karlsson MK; Ljunggren O; Vandenput L; Mellström D; Tivesten A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4406-14. PubMed ID: 20610590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone sulfate, incidence of myocardial infarction, and extent of atherosclerosis in men.
    LaCroix AZ; Yano K; Reed DM
    Circulation; 1992 Nov; 86(5):1529-35. PubMed ID: 1423966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
    Khaw KT
    J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
    Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.